Global X Aging Population ETF Rating $35.28 +0.01 (+0.03%) As of 05/13/2026 03:58 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Aging Population ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.AGNG Aggregate RatingModerate Buy 2.74Holdings in AGNG have an aggregate rating of Moderate Buy based on 338 analyst ratings issued in the past year covering 15 companies (43.2% of the portfolio).AGNG Aggregate Price Target$35.28High Prediction$35.28Average Prediction$35.28Low Prediction$35.28Holdings in AGNG have an aggregate price target of $35.28 and a range of $35.28 to $35.28 covering 15 companies (43.2% of the portfolio).AGNG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Aging Population ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 15 AGNG Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.27%EWEdwards Lifesciences$81.01-0.5%4.199 of 5 stars2.79$95.65 18.1%28Positive News3.25%WELLWelltower$219.66-0.2%3.4689 of 5 stars2.93$229.67 4.6%15Positive NewsAnalyst Forecast3.19%VTRVentas$90.25-0.1%3.324 of 5 stars2.82$94.00 4.2%17Positive NewsDividend AnnouncementAnalyst Forecast3.15%BMYBristol Myers Squibb$56.70+0.5%4.8332 of 5 stars2.37$61.31 8.1%19Positive NewsAnalyst Revision3.07%ABBVAbbVie$210.43+0.9%4.9385 of 5 stars2.88$252.90 20.2%25Positive NewsAnalyst ForecastAnalyst Revision3.03%LLYEli Lilly and Company$1,003.91-1.2%4.8921 of 5 stars2.87$1,218.33 21.4%30Trending NewsAnalyst Revision3.01%AMGNAmgen$336.12-0.1%3.8611 of 5 stars2.48$356.35 6.0%31Analyst Forecast2.94%JNJJohnson & Johnson$231.22+0.3%4.5965 of 5 stars2.74$253.04 9.4%27Trending NewsAnalyst Upgrade2.90%BSXBoston Scientific$52.89-0.3%4.4874 of 5 stars2.92$93.91 77.5%262.87%SYKStryker$299.43-0.9%4.9503 of 5 stars2.73$395.48 32.1%22Insider Trade2.85%REGNRegeneron Pharmaceuticals$717.42-0.3%4.3631 of 5 stars2.77$826.59 15.2%26Positive News2.84%MDTMedtronic$76.22+0.0%4.9614 of 5 stars2.58$107.80 41.4%26Positive NewsUpcoming Earnings2.76%MRKMerck & Co., Inc.$113.14-0.3%4.7417 of 5 stars2.68$128.18 13.3%19Positive NewsAnalyst Revision2.30%ONCBeOne Medicines$304.68-3.8%4.286 of 5 stars2.79$391.00 28.3%14News CoveragePositive News1.78%UTHRUnited Therapeutics$575.42-0.7%3.5498 of 5 stars2.85$619.42 7.6%13Insider Trade This page (NASDAQ:AGNG) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersThe US sanctioned itself out of world reserve status…Russia and Iran are both bypassing the US petrodollar - settling oil trades in alternative currencies while ce...Golden Portfolio | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | SponsoredCollect $1,170 a month from silverI've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...Investors Alley | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredSecret behind near perfectly timed stock trades…?After 20 years of professional trading, Ross Givens says this is the single most lucrative market strategy he ...Traders Agency | SponsoredIs this AI lab Elon’s SpaceX lifeline?Elon Musk went from calling one AI lab 'evil' to striking a deal giving it access to SpaceX's entire Colossus ...Chaikin Analytics | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Aging Population ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Aging Population ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
